Holen Sie sich die Stockscreener-App
1.96
4.81%
0.09
Schlusskurs vom Vortag:
$1.87
Offen:
$1.86
24-Stunden-Volumen:
283.16K
Relative Volume:
1.09
Marktkapitalisierung:
$104.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-2.3333
EPS:
-0.84
Netto-Cashflow:
$-18.45M
1W Leistung:
+0.51%
1M Leistung:
+22.50%
6M Leistung:
+96.00%
1J Leistung:
+182.42%
1-Tages-Spanne:
$1.8134
$1.98
1-Wochen-Bereich:
$1.62
$2.16
52-Wochen-Spanne:
$0.713
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Firmenname
Quince Therapeutics Inc
Sektor
Branche
Telefon
415-910-5717
Adresse
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Vergleichen Sie QNCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.95 | 100.44M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.45 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.07 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Eingeleitet | Oppenheimer | Outperform |
Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten
How to forecast Quince Therapeutics Inc. trends using time seriesWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Quince Therapeutics Inc. stock deliver shareholder valueJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - newser.com
Is Quince Therapeutics Inc. stock a good choice for value investorsPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
What hedge fund activity signals for Quince Therapeutics Inc. stockJuly 2025 Drop Watch & AI Powered Market Entry Strategies - newser.com
Is Quince Therapeutics Inc. trending in predictive chart models2025 Risk Factors & AI Enhanced Trade Execution Alerts - newser.com
Quince Therapeutics Inc. stock daily chart insightsMarket Risk Report & Fast Moving Stock Watchlists - newser.com
Quince Therapeutics' (QNCX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Tel - PharmiWeb.com
Quince Therapeutics presents A-T walking capacity data at neurology meeting By Investing.com - Investing.com Canada
Quince Therapeutics (QNCX) Highlights Walking Study at Neurology Meeting - GuruFocus
Quince Therapeutics presents A-T walking capacity data at neurology meeting - Investing.com
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting - Business Wire
Quince Therapeutics Inc. stock outlook for YEAREarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Visual trend scoring systems applied to Quince Therapeutics Inc.Risk Management & Real-Time Volume Analysis Alerts - newser.com
Has Quince Therapeutics Inc. formed a bullish divergenceEarnings Overview Report & High Return Stock Watch Alerts - newser.com
Can Quince Therapeutics Inc. stock hit analyst price targetsJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Analysts Set Quince Therapeutics, Inc. (NASDAQ:QNCX) PT at $8.14 - Defense World
Is Quince Therapeutics (NASDAQ:QNCX) Using Too Much Debt? - simplywall.st
What drives Quince Therapeutics Inc stock priceFinancial Sector Performance & Minimal Investment Capital - earlytimes.in
Will Quince Therapeutics Inc. bounce back from current supportWatch List & Reliable Price Breakout Alerts - newser.com
Applying Wyckoff theory to Quince Therapeutics Inc. stock2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Applying Elliott Wave Theory to Quince Therapeutics Inc.Recession Risk & Verified Momentum Watchlists - newser.com
Oppenheimer Sticks to Their Buy Rating for Quince Therapeutics (QNCX) - The Globe and Mail
Oppenheimer Maintains Quince Therapeutics(QNCX.US) With Buy Rating, Maintains Target Price $10 - 富途牛牛
Chart based analysis of Quince Therapeutics Inc. trendsJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Quince Therapeutics stock maintains Market Outperform rating at Citizens - Investing.com
Aqua Metals files to sell 1M shares of common stock for holders - MSN
Transcript : Quince Therapeutics, Inc.Analyst/Investor Day - MarketScreener
Quince Therapeutics (NASDAQ:QNCX) Stock Price Up 1.2% – Time to Buy? - Defense World
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):